Literature DB >> 29350049

Targeted and Off-Target (Bystander and Abscopal) Effects of Radiation Therapy: Redox Mechanisms and Risk/Benefit Analysis.

Jean-Pierre Pouget1, Alexandros G Georgakilas2, Jean-Luc Ravanat3.   

Abstract

SIGNIFICANCE: Radiation therapy (from external beams to unsealed and sealed radionuclide sources) takes advantage of the detrimental effects of the clustered production of radicals and reactive oxygen species (ROS). Research has mainly focused on the interaction of radiation with water, which is the major constituent of living beings, and with nuclear DNA, which contains the genetic information. This led to the so-called target theory according to which cells have to be hit by ionizing particles to elicit an important biological response, including cell death. In cancer therapy, the Poisson law and linear quadratic mathematical models have been used to describe the probability of hits per cell as a function of the radiation dose. Recent Advances: However, in the last 20 years, many studies have shown that radiation generates "danger" signals that propagate from irradiated to nonirradiated cells, leading to bystander and other off-target effects. CRITICAL ISSUES: Like for targeted effects, redox mechanisms play a key role also in off-target effects through transmission of ROS and reactive nitrogen species (RNS), and also of cytokines, ATP, and extracellular DNA. Particularly, nuclear factor kappa B is essential for triggering self-sustained production of ROS and RNS, thus making the bystander response similar to inflammation. In some therapeutic cases, this phenomenon is associated with recruitment of immune cells that are involved in distant irradiation effects (called "away-from-target" i.e., abscopal effects). FUTURE DIRECTIONS: Determining the contribution of targeted and off-target effects in the clinic is still challenging. This has important consequences not only in radiotherapy but also possibly in diagnostic procedures and in radiation protection.

Entities:  

Keywords:  abscopal effects; bystander effects; nontargeted effects; radionuclide therapy; radiotherapy; targeted effects

Mesh:

Substances:

Year:  2018        PMID: 29350049      PMCID: PMC6199630          DOI: 10.1089/ars.2017.7267

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  346 in total

1.  Induction of sister chromatid exchanges by extremely low doses of alpha-particles.

Authors:  H Nagasawa; J B Little
Journal:  Cancer Res       Date:  1992-11-15       Impact factor: 12.701

Review 2.  Vanguards of paradigm shift in radiation biology: radiation-induced adaptive and bystander responses.

Authors:  Hideki Matsumoto; Nobuyuki Hamada; Akihisa Takahashi; Yasuhiko Kobayashi; Takeo Ohnishi
Journal:  J Radiat Res       Date:  2007-02-28       Impact factor: 2.724

3.  Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli.

Authors:  Zhao-Hui Wu; Yuling Shi; Randal S Tibbetts; Shigeki Miyamoto
Journal:  Science       Date:  2006-02-24       Impact factor: 47.728

4.  DNA damage triggers a chronic autoinflammatory response, leading to fat depletion in NER progeria.

Authors:  Ismene Karakasilioti; Irene Kamileri; Georgia Chatzinikolaou; Theodoros Kosteas; Eleni Vergadi; Andria Rasile Robinson; Iannis Tsamardinos; Tania A Rozgaja; Sandra Siakouli; Christos Tsatsanis; Laura J Niedernhofer; George A Garinis
Journal:  Cell Metab       Date:  2013-09-03       Impact factor: 27.287

5.  A model for p53-induced apoptosis.

Authors:  K Polyak; Y Xia; J L Zweier; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

Review 6.  Key mechanisms involved in ionizing radiation-induced systemic effects. A current review.

Authors:  Ifigeneia V Mavragani; Danae A Laskaratou; Benjamin Frey; Serge M Candéias; Udo S Gaipl; Katalin Lumniczky; Alexandros G Georgakilas
Journal:  Toxicol Res (Camb)       Date:  2015-08-11       Impact factor: 3.524

Review 7.  Membrane transport of hydrogen peroxide.

Authors:  Gerd P Bienert; Jan K Schjoerring; Thomas P Jahn
Journal:  Biochim Biophys Acta       Date:  2006-03-10

8.  Radiation-induced adaptive response for protection against micronucleus formation and neoplastic transformation in C3H 10T1/2 mouse embryo cells.

Authors:  E I Azzam; G P Raaphorst; R E Mitchel
Journal:  Radiat Res       Date:  1994-04       Impact factor: 2.841

Review 9.  Current clinical trials testing combinations of immunotherapy and radiation.

Authors:  Marka Crittenden; Holbrook Kohrt; Ronald Levy; Jennifer Jones; Kevin Camphausen; Adam Dicker; Sandra Demaria; Silvia Formenti
Journal:  Semin Radiat Oncol       Date:  2015-01       Impact factor: 5.934

Review 10.  Mitochondria-associated membranes: composition, molecular mechanisms, and physiopathological implications.

Authors:  Carlotta Giorgi; Sonia Missiroli; Simone Patergnani; Jerzy Duszynski; Mariusz R Wieckowski; Paolo Pinton
Journal:  Antioxid Redox Signal       Date:  2015-03-13       Impact factor: 8.401

View more
  32 in total

Review 1.  Novel treatment planning approaches to enhance the therapeutic ratio: targeting the molecular mechanisms of radiation therapy.

Authors:  M Protopapa; V Kouloulias; A Kougioumtzopoulou; Z Liakouli; C Papadimitriou; A Zygogianni
Journal:  Clin Transl Oncol       Date:  2019-06-28       Impact factor: 3.405

2.  Associated guilt: radiation/bystanders.

Authors:  Hal E Broxmeyer
Journal:  Blood       Date:  2021-06-17       Impact factor: 22.113

3.  An investigation of the effects of N-acetylcysteine on radiotherapy-induced testicular injury in rats.

Authors:  Atilla Topcu; Filiz Mercantepe; Sema Rakici; Levent Tumkaya; Huseyin Avni Uydu; Tolga Mercantepe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-11-13       Impact factor: 3.000

Review 4.  Nuclear and Radiological Emergencies: Biological Effects, Countermeasures and Biodosimetry.

Authors:  Elena Obrador; Rosario Salvador-Palmer; Juan I Villaescusa; Eduardo Gallego; Blanca Pellicer; José M Estrela; Alegría Montoro
Journal:  Antioxidants (Basel)       Date:  2022-05-31

Review 5.  Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The "Hopeful Eight".

Authors:  Romain Eychenne; Michel Chérel; Férid Haddad; François Guérard; Jean-François Gestin
Journal:  Pharmaceutics       Date:  2021-06-18       Impact factor: 6.321

6.  Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy.

Authors:  Alan Pollack; Felix M Chinea; Elizabeth Bossart; Deukwoo Kwon; Matthew C Abramowitz; Charles Lynne; Merce Jorda; Brian Marples; Vivek N Patel; Xiaodong Wu; Isildinha Reis; Matthew T Studenski; Javier Casillas; Radka Stoyanova
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-02-19       Impact factor: 7.038

Review 7.  Atomic Nanogenerators in Targeted Alpha Therapies: Curie's Legacy in Modern Cancer Management.

Authors:  Mareike Roscher; Gábor Bakos; Martina Benešová
Journal:  Pharmaceuticals (Basel)       Date:  2020-04-23

8.  Astragalus polysaccharide inhibits radiation-induced bystander effects by regulating apoptosis in Bone Mesenchymal Stem Cells (BMSCs).

Authors:  Yi-Ming Zhang; Li-Ying Zhang; Heng Zhou; Yang-Yang Li; Kong-Xi Wei; Cheng-Hao Li; Ting Zhou; Ju-Fang Wang; Wen-Jun Wei; Jun-Rui Hua; Yun He; Tao Hong; Yong-Qi Liu
Journal:  Cell Cycle       Date:  2020-10-30       Impact factor: 4.534

Review 9.  Radiation-Induced Immunity and Toxicities: The Versatility of the cGAS-STING Pathway.

Authors:  Julie Constanzo; Julien Faget; Chiara Ursino; Christophe Badie; Jean-Pierre Pouget
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

Review 10.  GSTP1 as a novel target in radiation induced lung injury.

Authors:  Xiao Lei; Lehui Du; Wei Yu; Yao Wang; Na Ma; Baolin Qu
Journal:  J Transl Med       Date:  2021-07-08       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.